Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amgen
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Subjects currently undergoing every 4 weeks scheduled assessments in the phase 3 study 20050147
Subjects must sign the informed consent before any study specific procedures are performed
You may not be if
Developed sensitivity to mammalian cell derived drug products during the 20050147 study
Currently receiving any unapproved investigational product other than denosumab
Any disorder that, in the opinion of the investigator, may compromise the ability of the subject to give written informed consent and/or comply with study procedures
